Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-021058

Chief Operating Officer gave up 33,302 shares (to pay taxes)

  • Chief Operating Officer acquired 62,106 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BILINSKY IGOR · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-03 Exercise or conversion : show line 1 in the form +62,106 120,880 D
2025-03-03 Shares withheld for taxes : show line 2 in the form −33,302 $4.04 $134,540 87,578 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-03-03 Exercise or conversion : show line 3 in the form Restricted Stock Units −3,516 14,065 D
2025-03-03 Exercise or conversion : show line 4 in the form Restricted Stock Units −58,590 70,317 D
Loading xslF345X05/tm258333-4_4seq1.xml…